Treatments for Myelodysplastic syndrome associated with isolated del(5q) chromosome abnormality

FDA-approved drugs, patient assistance programs, and travel grants tracked on UniteRare for this condition.

ℹ

Treatment data is extracted from FDA drug labels, DailyMed, and openFDA through automated and AI-assisted pipelines that read both structured records and unstructured label text.

Report missing data

FDA-approved treatments (1)

Rytelo
IMETELSTAT SODIUM
Geron Corporation

Patient support programs (1)

Copay cards, manufacturer assistance, and foundation grants. Verification status shown on each card.

Rytelo

Geron Corporation

Rytelo — Contact Geron Corporation

Unverified — confirm before calling

Patient Assistance

Manufacturer Program

Accepting applications

More about Myelodysplastic syndrome associated with isolated del(5q) chromosome abnormality

Disease overview →
Specialists →
Clinical trials →